Isophane Protamine Human Insulin (30R) (Hec Pharm)

精蛋白人胰岛素 (30R) (宜昌东阳光)

Report date: 2025/01/07 14:46:57

Base Information

Drug NameIsophane Protamine Human Insulin (30R) (Hec Pharm)
Drug Alias Name精蛋白人胰岛素混合注射液 (30R)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2023/09/19
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHec Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHec Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A